A new study co-authored by Dimpy Shah, a researcher at the Mays Cancer Center, found that cancer patients with COVID-19 who were treated with the anti-viral medication remdesivir had lower mortality rates than those who weren’t.

Read and watch the story.

The post KSAT 12: UT Health San Antonio co-authored study shows how cancer patients with COVID-19 react to different treatments appeared first on UT Health San Antonio.